Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 10, 2000, Pages 2604-2608

  Connolly, P ^a   Wheat, L J ^a   Schnizlein Bick, C ^a   Durkin, M ^a   Kohler, S ^a   Smedema, M ^a   Goldberg, J ^a   Brizendine, E ^a   Loebenberg, D ^a  

^a Histoplasmosis Reference Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; ITRACONAZOLE; POSACONAZOLE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; IMMUNE DEFICIENCY; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

AMPHOTERICIN B; ANIMAL; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COMPARATIVE STUDY; HISTOPLASMA; HISTOPLASMOSIS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; ITRACONAZOLE; LUNG; MICE; MICE, INBRED STRAINS; SPLEEN; SUPPORT, NON-U.S. GOV'T; SURVIVAL ANALYSIS; TIME FACTORS; TRIAZOLES;

EID: 0033806931     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.10.2604-2608.2000     Document Type: Article

References (28)

1. Effect of antilymphocyte serum on animals experimentally infected with Histoplasma capsulatum or Cryptococcus neoformans
2. Intrapulmonary response to Histoplasma capsulatum in gamma interferon knockout mice
3. Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice
4. Rank transformations as a bridge between parametric and nonparametric statistics
5. Effect of cyclophosphamide on Histoplasma capsulatum infections in mice
6. Comparison of radioimmunoassay and enzyme-linked immunoassay methods for detection of Histoplasma capsulatum var. capsulatum antigen
7. Local immunity in lung-associated lymph nodes in a murine model of pulmonary histoplasmosis
8. + T cells in host defense against Histoplasma capsulatum
9. Histoplasmosis
10. Disseminated histoplasmosis: Clinical and pathologic correlations
11. Treatment of murine histoplasmosis with UK 49,858 (fluconazole)
12. Combination therapy of experimental histoplasmosis and cryptococcosis with amphotericin B and ketoconazole
13. Itraconazole maintenance treatment for histoplasmosis in AIDS: A prospective, multicenter trial
14. CD4-positive T lymphocytes are required for the generation of the primary but not the secondary CD8 positive cytolic T lymphocyte response to herpes simplex virus in C57BL/6 mice
15. Comparison of fluconazole with amphotericin B in treatment of histoplasmosis in normal and immunosuppressed mice
16. In vitro and in vivo activities of SCH 39304, fluconazole and amphotericin B against Histoplasma capsulatum
17. Clearance of Histoplasma capsulatum variety capsulatum antigen is useful for monitoring treatment of experimental histoplasmosis
18. Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: Incidence, risk factors and pathophysiology
19. Clinical and laboratory features of disseminated histoplasmosis during two large urban outbreaks
20. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome
21. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome
22. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome
23. Histoplasmosis in the acquired immunodeficiency syndrome
24. Disseminated histoplasmosis in the acquired immune deficiency syndrome: Clinical findings, diagnosis and treatment and review of the literature
25. Histoplasma capsulatum infection in nude mice
26. Quantitative plating of Histoplasma capsulatum without addition of conditioned medium or siderophores
27. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma
28. Interleukin-12 modulates the protective immune response in SCID mice infected with Histoplasma capsulatum